Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

4178 - Association between systemic inflammation and symptoms in advanced cancer patients


10 Sep 2017


Poster display session


Supportive Care and Symptom Management


David Viñal Lozano


Annals of Oncology (2017) 28 (suppl_5): v543-v567. 10.1093/annonc/mdx388


D. Viñal Lozano1, A. Alonso-Babarro2, Y. Vilches-Aguirre2, L. Diez-Porres2, M. Varela-Cerdeira2, J. Villamayor Sanchez1, L. Gutierrez Sainz1, R. Madero-Jarabo2

Author affiliations

  • 1 Medical Oncology, Hospital Universitario La Paz, 28046 - Madrid/ES
  • 2 Acute Palliative Care Unit, Hospital Universitario La Paz, 28046 - Madrid/ES


Abstract 4178


There is growing evidence relating inflammation as a prognostic factor in cancer patients. Previous reports have found a small but significant association between systemic inflammation and symptoms in advanced cancer patients. The aim of this study was to analyse the relationship between systemic inflammatory response markers with the symptoms and performance status of advanced cancer patients that have been admitted to an Acute Palliative Care Unit (PCU).


We conducted an observational study including all cancer patients admitted in the PCU between January 2012 and April 2015. We performed a correlation analysis (spearman’s rho) between serum C-reactive-protein (CRP), the modified Glasgow Prognostic Score (mGPS) and Neutrophil-to Lymphocyte Ratio (NLR) with patients symptoms recorded as the Edmonton Symptom Assessment Sytem (ESAS) and performance status recorded as Eastern Cooperative Oncology Group (ECOG), Barthel Index and Palliative Performance Scale (PPS). All data were collected within the first two days of admission.


Data of 951 patients were available. The median survival was 17 days. CRP was significantly correlated with ECOG (ρ:0.180, P:0.000), dyspnoea (ρ:0.079, p:0.019), fatigue (ρ:0.162, p 


There is a small but significant correlation between systemic inflammation and symptoms. Further studies are needed to confirm the results and to test this relation in earlier phases of the disease.

Clinical trial identification

Legal entity responsible for the study

Hospital Universitario La Paz




All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.